Digestive and Metabolic Diseases

Digestive System Cancers

Digestive system cancers encompass malignancies of the esophagus, stomach, liver, pancreas, colon, and rectum. These cancers often progress silently, making early diagnosis challenging. Colorectal and pancreatic cancers, in particular, carry high morbidity and mortality rates due to late detection and limited treatment options. Advancements in imaging technologies, biomarker discovery, molecular profiling, and personalized therapies have improved diagnostic precision and treatment outcomes.

This session delves into the epidemiology, risk factors, and genetic predispositions for digestive cancers. It will cover novel treatment modalities such as immunotherapy, targeted therapy, and precision oncology. Emphasis will also be placed on cancer screening programs, surveillance strategies for high-risk populations, and the role of diet and lifestyle in prevention.

Key Topics:

• Colorectal, gastric, and pancreatic cancers

• Cancer screening and early detection

• Tumor markers and molecular diagnostics

• Role of genetics in cancer susceptibility

• Immunotherapy and targeted treatments

• Surgical approaches and outcomes

• Chemotherapy and radiotherapy updates

• Lifestyle risk factors and prevention

• Survivorship and palliative care

• Emerging clinical trials and innovations